<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2015-12-01" updated="2019-12-02">
  <drugbank-id primary="true">DB10789</drugbank-id>
  <name>Bordetella pertussis pertactin antigen</name>
  <description>Bordetella pertussis pertactin antigen is a vaccine for the prophylaxis of whooping cough that contains pertactin, a membrane-associated antigen of Bordetella pertussis [A31248].</description>
  <cas-number/>
  <unii>63GD90PP8X</unii>
  <groups>
    <group>approved</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A31248</ref-id>
        <pubmed-id>9325433</pubmed-id>
        <citation>Pagliaccia C, Manetti R, Rappuoli R: Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point. Arch Microbiol. 1997 Nov;168(5):437-40.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Bordetella pertussis pertactin vaccine, inactivated</synonym>
    <synonym language="english" coder="">Pertactin</synonym>
    <synonym language="english" coder="">Pertactin adsorbed</synonym>
  </synonyms>
  <products>
    <product>
      <name>Adacel TDaP</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-400</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-06-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125111</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adacel TDaP TDaP</name>
      <labeller>Remedy Repack</labeller>
      <ndc-id/>
      <ndc-product-code>52125-848</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-11-14</started-marketing-on>
      <ended-marketing-on>2016-03-29</ended-marketing-on>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125111</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-1079</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-06-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125111</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Daptacel</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-286</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-05-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA103666</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pentacel</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-510</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-06-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125145</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Quadracel</name>
      <labeller>Sanofi Pasteur Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49281-562</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125525</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vaxelis</name>
      <labeller>MCM Vaccine Co.</labeller>
      <ndc-id/>
      <ndc-product-code>63361-245</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-12-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, suspension</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number>BLA125563</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Adacel TDaP TDaP</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Daptacel</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Vaxelis</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) + Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen + Hepatitis B Vaccine (Recombinant) + Poliovirus type 1 antigen (formaldehyde inactivated) + Poliovirus type 2 antigen (formaldehyde inactivated) + Poliovirus type 3 antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Adacel TDaP</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Quadracel</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) + Poliovirus type 1 antigen (formaldehyde inactivated) + Poliovirus type 2 antigen (formaldehyde inactivated) + Poliovirus type 3 antigen (formaldehyde inactivated)</ingredients>
    </mixture>
    <mixture>
      <name>Pentacel</name>
      <ingredients>Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) + Bordetella pertussis fimbriae 2/3 antigen + Bordetella pertussis pertactin antigen + Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) + Clostridium tetani toxoid antigen (formaldehyde inactivated) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) + Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen + Poliovirus type 1 antigen (formaldehyde inactivated) + Poliovirus type 2 antigen (formaldehyde inactivated) + Poliovirus type 3 antigen (formaldehyde inactivated)</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Bacterial Proteins</category>
      <mesh-id>D001426</mesh-id>
    </category>
    <category>
      <category>Bacterial Toxins</category>
      <mesh-id>D001427</mesh-id>
    </category>
    <category>
      <category>Biological Factors</category>
      <mesh-id>D001685</mesh-id>
    </category>
    <category>
      <category>Bordetella bronchiseptica</category>
      <mesh-id>D016950</mesh-id>
    </category>
    <category>
      <category>Bordetella pertussis</category>
      <mesh-id>D001886</mesh-id>
    </category>
    <category>
      <category>Membrane Proteins</category>
      <mesh-id>D008565</mesh-id>
    </category>
    <category>
      <category>Proteins</category>
      <mesh-id>D011506</mesh-id>
    </category>
    <category>
      <category>Toxins, Biological</category>
      <mesh-id>D014118</mesh-id>
    </category>
    <category>
      <category>Virulence Factors</category>
      <mesh-id>D037521</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection, suspension</form>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
    <dosage>
      <form/>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347910899</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>